MedTrace Logo

HR-EEG Contribution in Prognostic Evaluation of Language Development in Children With ASD

NCT05586672 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-10-19

No results posted yet for this study

Summary

The goal of this prospective observational multicentric cohort study is to evaluate the clinical prognostic value of the speech tracking score of language development in children with ASD aged from 3 years to 4 years and half at inclusion.

Participants will followed during 4 years with an annual visit. During these visits, each participant will be clinically evaluated (scales and tests) and performed an EEG-HR recording. Two groups will be formed, one with children diagnosed with ASD with language delay, and a control group composed of non-ASD children without language delay, matched on age and gender with the ASD group.

Conditions

Interventions

DEVICE

EEG-HR

Passation EEG-HR

DIAGNOSTIC_TEST

ADI-R

Passation of ADI-R scale

DIAGNOSTIC_TEST

ADOS-2

Passation of ADOS-2 scale

DIAGNOSTIC_TEST

IDE

Passation of IDE scale

DIAGNOSTIC_TEST

MSEL

Passation of MSEL scale

DIAGNOSTIC_TEST

Dunn

Passation of Dunn scale

Sponsors & Collaborators

  • Etablissement Public de Santé Barthélemy Durand

    lead OTHER

Principal Investigators

  • Mariette Vinurel · Etablissement Public de Santé Barthélemy Durand

Eligibility

Min Age
3 Years
Max Age
4 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-02
Primary Completion
2027-01-31
Completion
2028-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05586672 on ClinicalTrials.gov